胃癌術前分期及確定生物學特性的策略和方法_《中國普外基礎與臨床雜志》

作者：

顧晉 , 王洪義

北京大學臨床腫瘤學院外二科(北京100036);

關鍵詞：

胃癌術前分期預后

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 顧晉,王洪義. 胃癌術前分期及確定生物學特性的策略和方法. 中國普外基礎與臨床雜志, 2006, 13(1): 12-14. doi: 復制

1.	14Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer [J]. Clin Cancer Res, 2000; 6(11)∶4234 15Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(6)∶632.
2.	嚴仲瑜，萬遠廉. 消化道腫瘤外科學 [M]. 北京: 北京大學醫學出版社， 2003∶194~200.
3.	廖盛日，陳敏華，霍苓, 等. 體表超生對胃癌浸潤深度的診斷 [J]. 中國超聲雜志， 2003; 19（8）∶601.
4.	Akahoshi K, Misawa T, Fujishima H, et al. Regional lymph node metastasis in gastric cancer: evaluation with endoscopic US [J]. Radiology， 1992; 182(2)∶559.
5.	Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in Tstaging of gastric cancer [J]. J Comput Assist Tomogr, 1997; 21(1)∶73.
6.	Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J]. Cancer, 2005; 103(11)∶2383.
7.	Lee DH, Ko YT, Park SJ, et al. Comparison of hydroUS and spiral CT in the staging of gastric cancer [J]. Clin Imaging, 2001; 25(3)∶181.
8.	Davies J, Chalmers AG, SueLing HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging [J]. Gut， 1997; 41(3)∶314.
9.	Marrelli D, Roviello F, De Stefano A, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection [J]. J Am Coll Surg， 2004; 198(1)∶51.
10.	Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients: a prospective clinical study [J]. Gastric Cancer, 2003; 6(3)∶142.
11.	Lai IR,Lee WJ,Huang MT,et al.Comparison of serum CA724,CEA,TPA,CA199 and CA125 levels in gastric cancer patients and correlation with recurrence [J]. Hepatogastroenterology, 2002; 49(46)∶1157.
12.	Sato T, Nishimura G, Nonomura A, et al. Serological studies on CEA, CA 199, STn and SLX in colorectal cancer [J]. Hepatogastroenterology, 1999; 46(26)∶914.
13.	Yonemura Y, Endou Y, Fujita H, et al. Role of MMP7 in the formation of peritoneal dissemination in gastric cancer [J]. Gastric Cancer, 2000; 3(2)∶63.
14.	PintodeSousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma [J]. Virchows Arch, 2002; 440(3)∶304.

1. 14Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer [J]. Clin Cancer Res, 2000; 6(11)∶4234 15Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(6)∶632.
2. 嚴仲瑜，萬遠廉. 消化道腫瘤外科學 [M]. 北京: 北京大學醫學出版社， 2003∶194~200.
3. 廖盛日，陳敏華，霍苓, 等. 體表超生對胃癌浸潤深度的診斷 [J]. 中國超聲雜志， 2003; 19（8）∶601.
4. Akahoshi K, Misawa T, Fujishima H, et al. Regional lymph node metastasis in gastric cancer: evaluation with endoscopic US [J]. Radiology， 1992; 182(2)∶559.
5. Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in Tstaging of gastric cancer [J]. J Comput Assist Tomogr, 1997; 21(1)∶73.
6. Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J]. Cancer, 2005; 103(11)∶2383.
7. Lee DH, Ko YT, Park SJ, et al. Comparison of hydroUS and spiral CT in the staging of gastric cancer [J]. Clin Imaging, 2001; 25(3)∶181.
8. Davies J, Chalmers AG, SueLing HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging [J]. Gut， 1997; 41(3)∶314.
9. Marrelli D, Roviello F, De Stefano A, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection [J]. J Am Coll Surg， 2004; 198(1)∶51.
10. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients: a prospective clinical study [J]. Gastric Cancer, 2003; 6(3)∶142.
11. Lai IR,Lee WJ,Huang MT,et al.Comparison of serum CA724,CEA,TPA,CA199 and CA125 levels in gastric cancer patients and correlation with recurrence [J]. Hepatogastroenterology, 2002; 49(46)∶1157.
12. Sato T, Nishimura G, Nonomura A, et al. Serological studies on CEA, CA 199, STn and SLX in colorectal cancer [J]. Hepatogastroenterology, 1999; 46(26)∶914.
13. Yonemura Y, Endou Y, Fujita H, et al. Role of MMP7 in the formation of peritoneal dissemination in gastric cancer [J]. Gastric Cancer, 2000; 3(2)∶63.
14. PintodeSousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma [J]. Virchows Arch, 2002; 440(3)∶304.

《中國普外基礎與臨床雜志》

胃癌術前分期及確定生物學特性的策略和方法

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

胃癌術前分期及確定生物學特性的策略和方法

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料